Is AbbVie Inc. (ABBV) the Best Cancer Stock to Buy Now?

By Yahoo! Finance | Sep 3, 2024 at 11:43 PM EST

The global oncology market is rapidly growing, with an expected value of over $470 billion by 2032. AbbVie Inc. is a leading player, making strides in cancer treatment development and acquisitions. Despite strong performance, its valuation remains reasonable, presenting potential for future growth.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.